Victory Capital Management’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6M Buy
337,880
+258,029
+323% +$11.1M 0.01% 990
2025
Q1
$2.76M Buy
79,851
+14,825
+23% +$513K ﹤0.01% 1452
2024
Q4
$1.78M Sell
65,026
-312,156
-83% -$8.57M ﹤0.01% 1540
2024
Q3
$9.6M Sell
377,182
-5,535
-1% -$141K 0.01% 1119
2024
Q2
$9.69M Buy
382,717
+34,360
+10% +$870K 0.01% 1091
2024
Q1
$10.8M Sell
348,357
-111,212
-24% -$3.44M 0.01% 1040
2023
Q4
$18.6M Buy
459,569
+24,156
+6% +$975K 0.02% 805
2023
Q3
$11.5M Sell
435,413
-118,320
-21% -$3.12M 0.01% 965
2023
Q2
$9.52M Buy
553,733
+541,690
+4,498% +$9.32M 0.01% 1063
2023
Q1
$200K Sell
12,043
-73,253
-86% -$1.21M ﹤0.01% 2251
2022
Q4
$650K Sell
85,296
-66,625
-44% -$508K ﹤0.01% 1923
2022
Q3
$1.51M Buy
151,921
+50,556
+50% +$502K ﹤0.01% 1541
2022
Q2
$920K Buy
101,365
+949
+0.9% +$8.61K ﹤0.01% 1787
2022
Q1
$989K Sell
100,416
-1,603
-2% -$15.8K ﹤0.01% 1819
2021
Q4
$1.7M Buy
102,019
+91,010
+827% +$1.52M ﹤0.01% 1612
2021
Q3
$516K Sell
11,009
-283
-3% -$13.3K ﹤0.01% 2158
2021
Q2
$688K Sell
11,292
-1,291
-10% -$78.7K ﹤0.01% 2034
2021
Q1
$775K Buy
12,583
+1,290
+11% +$79.5K ﹤0.01% 2022
2020
Q4
$803K Buy
11,293
+789
+8% +$56.1K ﹤0.01% 1881
2020
Q3
$394K Sell
10,504
-69,456
-87% -$2.61M ﹤0.01% 2045
2020
Q2
$2.61M Sell
79,960
-94,012
-54% -$3.07M ﹤0.01% 1350
2020
Q1
$5.05M Buy
173,972
+83,682
+93% +$2.43M ﹤0.01% 1266
2019
Q4
$3.17M Sell
90,290
-711,699
-89% -$24.9M ﹤0.01% 1347
2019
Q3
$17.2M Buy
801,989
+170,200
+27% +$3.65M 0.02% 849
2019
Q2
$17M Buy
+631,789
New +$17M 0.03% 655